Patients’ priorities around drug-resistant tuberculosis treatment: A multi-national qualitative study from Mongolia, South Africa and Georgia

References

• Abdulelah, J., Sulaiman, S. A. S., Hassali, M. A., Blebil, A. Q., Awaisu, A., & Bredle, J. M. (2015). Development and psychometric properties of a tuberculosis-specific multidimensional health-related quality-of-life measure for patients with pulmonary tuberculosis. Value in Health Regional Issues, 6, 53–59. https://doi.org/10.1016/j.vhri.2015.03.006
   PubMedGoogle Scholar
• Berry, C., du Cros, P., Fielding, K., Gajewski, S., Kazounis, E., McHugh, T. D., Merle, C., Motta, I., Moore, D. A. J., & Nyang'wa, B. T. (2022). TB-PRACTECAL: Study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis. Trials, 23(1), 484. https://doi.org/10.1186/s13063-022-06331-8
   PubMedGoogle Scholar
• Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa
   Google Scholar
• Braun, V., & Clarke, V. (2019). Reflecting on reflexive thematic analysis. Qualitative Research in Sport, Exercise and Health, 11(4), 589–597. https://doi.org/10.1080/2159676X.2019.1628806
   Web of Science ®Google Scholar
• Burgess, R., & Campbell, C. (2014). Contextualising women's mental distress and coping strategies in the time of AIDS: A rural South African case study. Transcultural Psychiatry, 51(6), 875–903. https://doi.org/10.1177/1363461514526925
   PubMed Web of Science ®Google Scholar
• Burtscher, D., Juul Bjertrup, P., Vambe, D., Dlamini, V., Mmema, N., Ngwenya, S., Rusch, B., & Kerschberger, B. (2021). ‘She is like my mother’: Community-based care of drug-resistant tuberculosis in rural Eswatini. Global Public Health, 16(6), 911–923. https://doi.org/10.1080/17441692.2020.1808039
   PubMed Web of Science ®Google Scholar
• Clarke, V., Braun, V., Frith, H., & Moller, N. (2019). Editorial introduction to the special issue: Using story completion methods in qualitative research. Qualitative Research in Psychology, 16(1), 1–20. https://doi.org/10.1080/14780887.2018.1536378
   Web of Science ®Google Scholar
• Clarke, V., Hayfield, N., Moller, N. P., & Tischner, I. (2017). Once upon a time … : qualitative story completion methods. In V. Braun, V. Clarke, & D. Gray (Eds.), Collecting qualitative data: A practical guide to textual, media and virtual techniques (pp. 45–70). Cambridge University PRess.
   Google Scholar
• Conradie, F., Bagdasaryan, T. R., Borisov, S., Howell, P., Mikiashvili, L., Ngubane, N., Samoilova, A., Skornykova, S., Tudor, E., Variava, E., Yablonskiy, P., Everitt, D., Wills, G. H., Sun, E., Olugbosi, M., Egizi, E., Li, M., Holsta, A., Timm, J., … ZeNix Trial, T. (2022). Bedaquiline-Pretomanid-Linezolid regimens for drug-resistant tuberculosis. New England Journal of Medicine, 387(9), 810–823. https://doi.org/10.1056/NEJMoa2119430
   PubMed Web of Science ®Google Scholar
• Conradie, F., Everitt, D., & Crook, A. M. (2020). Treatment of highly drug-resistant pulmonary tuberculosis. New England Journal of Medicine, 382(24), 2376–2377. https://doi.org/10.1056/NEJMc2009939
   Google Scholar
• Daftary, A., Mondal, S., Zelnick, J., Friedland, G., Seepamore, B., Boodhram, R., Amico, K. R., Padayatchi, N., & O'Donnell, M. R. (2021). Dynamic needs and challenges of people with drug-resistant tuberculosis and HIV in South Africa: A qualitative study. The Lancet Global Health, 9(4), e479–e488. https://doi.org/10.1016/S2214-109X(20)30548-9
   PubMed Web of Science ®Google Scholar
• Dion, M. J., Tousignant, P., Bourbeau, J., Menzies, D., & Schwartzman, K. (2004). Feasibility and reliability of health-related quality of life measurements among tuberculosis patients. Quality of Life Research, 13(3), 653–665. https://doi.org/10.1023/B:QURE.0000021320.89524.64
   PubMed Web of Science ®Google Scholar
• Dujaili, J. A., Sulaiman, S. A., Hassali, M. A., Awaisu, A., Blebil, A. Q., & Bredle, J. M. (2015). Health-related quality of life as a predictor of tuberculosis treatment outcomes in Iraq. International Journal of Infectious Diseases, 31, 4–8. https://doi.org/10.1016/j.ijid.2014.12.004
   PubMed Web of Science ®Google Scholar
• Ferrer, M., Villasante, C., Alonso, J., Sobradillo, V., Gabriel, R., Vilagut, G., Masa, J. F., Viejo, J. L., Jimenez-Ruiz, C. A., & Miravitlles, M. (2002). Interpretation of quality of life scores from the St george's respiratory questionnaire. European Respiratory Journal, 19(3), 405–413. https://doi.org/10.1183/09031936.02.00213202
   PubMed Web of Science ®Google Scholar
• Fu, S. N., Dao, M. C., Wong, C. K., & Yu, W. C. (2019). SF-6D utility scores of smokers and ex-smokers with or without respiratory symptoms attending primary care clinics. Health and Quality of Life Outcomes, 17(1), 48. https://doi.org/10.1186/s12955-019-1115-z
   PubMedGoogle Scholar
• Goodall, R. L., Meredith, S. K., Nunn, A. J., Bayissa, A., Bhatnagar, A. K., Bronson, G., Chiang, C.-Y., Conradie, F., Gurumurthy, M., Kirenga, B., Kiria, N., Meressa, D., Moodliar, R., Narendran, G., Ngubane, N., Rassool, M., Sanders, K., Solanki, R., Squire, S. B., … Zagd, C. (2022). Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): An open-label, multicentre, randomised, non-inferiority trial. The Lancet, 400(10366), 1858–1868. https://doi.org/10.1016/S0140-6736(22)02078-5
   PubMed Web of Science ®Google Scholar
• Gravett, K. (2019). Story completion: Storying as a method of meaning-making and discursive discovery. International Journal of Qualitative Methods, 18. https://doi.org/10.1177/1609406919893155
   PubMed Web of Science ®Google Scholar
• Hawthorne, G., Herrman, H., & Murphy, B. (2006). Interpreting the WHOQOL-brèf: Preliminary population norms and effect sizes. Social Indicators Research, 77(1), 37–59. https://doi.org/10.1007/s11205-005-5552-1
   Web of Science ®Google Scholar
• Hoppe, L. E. (2016). Developing core outcome sets for clinical research and guideline development – qualitative systematic reviews to increase the volume, depth and diversity of patient perspectives included. Tuberculosis: A case study. University of Manchester].
   Google Scholar
• Kastien-Hilka, T., Abulfathi, A., Rosenkranz, B., Bennett, B., Schwenkglenks, M., & Sinanovic, E. (2016). Health-related quality of life and its association with medication adherence in active pulmonary tuberculosis- a systematic review of global literature with focus on South Africa. Health and Quality of Life Outcomes, 14(1), 42. https://doi.org/10.1186/s12955-016-0442-6
   PubMedGoogle Scholar
• Kastien-Hilka, T., Rosenkranz, B., Sinanovic, E., Bennett, B., & Schwenkglenks, M. (2017). Health-related quality of life in South African patients with pulmonary tuberculosis. PLoS One, 12(4), e0174605. https://doi.org/10.1371/journal.pone.0174605
   PubMed Web of Science ®Google Scholar
• Lins, L., & Carvalho, F. M. (2016). SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Medicine, 4. https://doi.org/10.1177/2050312116671725
   PubMedGoogle Scholar
• Loveday, M., Hlangu, S., Larkan, L. M., Cox, H., Daniels, J., Mohr-Holland, E., & Furin, J. (2021). “This is not my body”: therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis. PLoS One, 16(10), e0251482. https://doi.org/10.1371/journal.pone.0251482
   PubMed Web of Science ®Google Scholar
• Martinez, T. Y., Pereira, C. A., dos Santos, M. L., Ciconelli, R. M., Guimaraes, S. M., & Martinez, J. A. (2000). Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis. Chest, 117(6), 1627–1632. https://doi.org/10.1378/chest.117.6.1627
   PubMed Web of Science ®Google Scholar
• Mathai, S. C., Ghofrani, H. A., Mayer, E., Pepke-Zaba, J., Nikkho, S., & Simonneau, G. (2016). Quality of life in patients with chronic thromboembolic pulmonary hypertension. European Respiratory Journal, 48(2), 526–537. https://doi.org/10.1183/13993003.01626-2015
   PubMed Web of Science ®Google Scholar
• Nahid, P., Mase, S. R., Migliori, G. B., Sotgiu, G., Bothamley, G. H., Brozek, J. L., Cattamanchi, A., Cegielski, J. P., Chen, L., Daley, C. L., Dalton, T. L., Duarte, R., Fregonese, F., Horsburgh Jr, C. R., Ahmad Khan, F., Kheir, F., Lan, Z., Lardizabal, A., Lauzardo, M., … Seaworth, B. (2019). Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline. American Journal of Respiratory and Critical Care Medicine, 200(10), e93–e142. https://doi.org/10.1164/rccm.201909-1874ST
   PubMed Web of Science ®Google Scholar
• Nigam, S., Sharma, R. K., Yadav, R., Rao, V. G., Mishra, P., Lingala, M. A., & Bhat, J. (2021). Experiences and needs of patients with MDR/XDR-TB: A qualitative study among Saharia tribe in Madhya Pradesh, Central India. Bmj Open, 11(8), e044698. https://doi.org/10.1136/bmjopen-2020-044698
   PubMed Web of Science ®Google Scholar
• Numpong, S., Kengganpanich, M., Kaewkungwal, J., Pan-Ngum, W., Silachamroon, U., Kasetjaroen, Y., & Lawpoolsri, S. (2022). Confronting and coping with multidrug-resistant tuberculosis: Life experiences in Thailand. Qualitative Health Research, 32(1), 159–167. https://doi.org/10.1177/10497323211049777
   PubMed Web of Science ®Google Scholar
• Ohrnberger, J., Anselmi, L., Fichera, E., & Sutton, M. (2020). Validation of the SF12 mental and physical health measure for the population from a low-income country in sub-Saharan Africa. Health and Quality of Life Outcomes, 18(1), 78. https://doi.org/10.1186/s12955-020-01323-1
   PubMed Web of Science ®Google Scholar
• Park, H. Y., Cheon, H. B., Choi, S. H., & Kwon, J. W. (2021). Health-Related quality of life based on EQ-5D utility score in patients With tuberculosis: A systematic review. Frontiers in Pharmacology, 12, 659675. https://doi.org/10.3389/fphar.2021.659675
   PubMedGoogle Scholar
• Saleem, S., Malik, A. A., Ghulam, A., Ahmed, J., & Hussain, H. (2018). Health-related quality of life among pulmonary tuberculosis patients in Pakistan. Quality of Life Research, 27(12), 3137–3143. https://doi.org/10.1007/s11136-018-1954-9
   PubMed Web of Science ®Google Scholar
• Santos, F. L. D., Souza, L. L. L., Bruce, A. T. I., Crispim, J. A., Arroyo, L. H., Ramos, A. C. V., Berra, T. Z., Alves, Y. M., Scholze, A. R., Costa, F., Martoreli Júnior, J. F., Moncaio, A. C. S., Pinto, I. C., & Arcêncio, R. A. (2021). Patients’ perceptions regarding multidrug-resistant tuberculosis and barriers to seeking care in a priority city in Brazil during COVID-19 pandemic: A qualitative study. PLoS One, 16(4), e0249822. https://doi.org/10.1371/journal.pone.0249822
   PubMed Web of Science ®Google Scholar
• Soh, S. E., Morello, R., Ayton, D., Ahern, S., Scarborough, R., Zammit, C., Brand, M., Stirling, R. G., & Zalcberg, J. (2021). Measurement properties of the 12-item short form health survey version 2 in Australians with lung cancer: A Rasch analysis. Health and Quality of Life Outcomes, 19(1), 157. https://doi.org/10.1186/s12955-021-01794-w
   PubMed Web of Science ®Google Scholar
• Spencer, S., Calverley, P. M., Sherwood Burge, P., Jones, P. W., & Disease, I. S. G. I. S. i. O. L. (2001). Health status deterioration in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 163(1), 122–128. https://doi.org/10.1164/ajrccm.163.1.2005009
   PubMed Web of Science ®Google Scholar
• Summerfield, D. (2012). Afterword: Against “global mental health”. Transcultural Psychiatry, 49(3-4), 519–530. https://doi.org/10.1177/1363461512454701
   PubMed Web of Science ®Google Scholar
• Udwadia, Z., & Furin, J. (2019). Quality of drug-resistant tuberculosis care: Gaps and solutions. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 16, 100101. https://doi.org/10.1016/j.jctube.2019.100101
   PubMedGoogle Scholar
• Working Group on New TB Drugs, S. T. P. (2022). Clinical pipeline. Stop TB Partnership. Retrieved 27/10/2022 from https://www.newtbdrugs.org/pipeline/clinical.
   Google Scholar
• World Health Organisation. (2020). WHO consolidated guidelines on tuberculosis: Module 4: Treatment - drug-resistant tuberculosis treatment. https://www.who.int/publications/i/item/9789240007048.
   Google Scholar
• World Health Organisation. (2022a). Global tuberculosis report. W. H. Organisation.
   Google Scholar
• World Health Organisation. (2022b). Rapid communication: Key changes to the treatment of drug-resistant tuberculosis (WHO/UCN/TB/2022.2). https://www.who.int/publications/i/item/WHO-UCN-TB-2022-2.
   Google Scholar
• World Health Organisation. (2022c). Tackling the drug-resistant TB crisis. Retrieved July 15, 2022, from https://www.who.int/activities/tackling-the-drug-resistant-tb-crisis.
   Google Scholar
• Wu, A. W., Revicki, D. A., Jacobson, D., & Malitz, F. E. (1997). Evidence for reliability, validity and usefulness of the medical outcomes study HIV health survey (MOS-HIV). Quality of Life Research, 6(6), 481–493. https://doi.org/10.1023/A:1018451930750
   PubMed Web of Science ®Google Scholar
• Wu, A. W., Rubin, H. R., Mathews, W. C., Ware Jr, J. E., Brysk, L. T., Hardy, W. D., Bozzette, S. A., Spector, S. A., & Richman, D. D. (1991). A health status questionnaire using 30 items from the medical outcomes study. Medical Care, 29(8), 786–798. https://doi.org/10.1097/00005650-199108000-00011
   PubMed Web of Science ®Google Scholar
• Wu, S., Zhang, Y., Sun, F., Chen, M., Zhou, L., Wang, N., & Zhan, S. (2016). Adverse events associated With the treatment of multidrug-resistant tuberculosis: A systematic review and meta-analysis. American Journal of Therapeutics, 23(2), https://journals.lww.com/americantherapeutics/Fulltext/2016/03000/Adverse_Events_Associated_With_the_Treatment_of.24.aspx.
   Web of Science ®Google Scholar
• Xu, W., Collet, J. P., Shapiro, S., Lin, Y., Yang, T., Wang, C., & Bourbeau, J. (2009). Validation and clinical interpretation of the St George's respiratory questionnaire among COPD patients, China. The international Journal of Tuberculosis and Lung Disease, 13(2), 181–189.
   PubMed Web of Science ®Google Scholar